Mesoblast

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.61-$19.14
Market Cap
$1.1B
Shares Short
1M

Financials

See more
Revenue (12 Mos)
$5.9M
Revenue Growth (YoY)
-41.2%
Gross Profit (12 Mos)
-$47.4M
Diluted EPS
-$1.05

News

See more

Yahoo Finance • 4 months ago

Is Mesoblast (MESO) The Best Australian Stock To Buy According to Hedge Funds?

Yahoo Finance • 11 months ago

10 Best Australian Stocks To Buy

Yahoo Finance • last year

Mesoblast Files for Orphan Drug and Pediatric Rare Disease Designations for Rexlemestrocel-L as Treatment for Severe Congenital Heart Disease

Yahoo Finance • last year

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mesoblast Limited - MESO

About

CEO
Dr. Silviu Itescu FACP, FACRA, FRACP, MBBS (Hons)
Address
55 Collins Street, Melbourne, VIC, Australia, 3000
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
73